IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies

MLA

Katherine M. Audsley, et al. “IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies.” Frontiers in Immunology, vol. 12, Sept. 2021. EBSCOhost, https://doi.org/10.3389/fimmu.2021.735133.

APA

Katherine M. Audsley, Teagan Wagner, Clara Ta, Hannah V. Newnes, Anthony C. Buzzai, Samantha A. Barnes, Ben Wylie, Jesse Armitage, Tsuneyasu Kaisho, Anthony Bosco, Alison McDonnell, Mark Cruickshank, Vanessa S. Fear, Bree Foley, & Jason Waithman. (2021). IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.735133

Chicago

Katherine M. Audsley, Teagan Wagner, Clara Ta, Hannah V. Newnes, Anthony C. Buzzai, Samantha A. Barnes, Ben Wylie, et al. 2021. “IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies.” Frontiers in Immunology 12 (September). doi:10.3389/fimmu.2021.735133.